Atlas Trials

177Lutetium-octreotate Treatment Prediction Using Multimodality Imaging in Refractory NETs

Clinical trial NCT01842165 · COMPLETED

Trial details

NCT number
NCT01842165
Sponsor
Jules Bordet Institute
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Gastroenteropancreatic Neuroendocrine Tumors
Start date
2013-05-01
Primary completion
2022-01-14
Enrollment
37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.